2022 Presenting Companies
MedGene Therapeutics, Inc. is a cell and gene therapy start-up company (late pre-clinical stage) based in Gaithersburg, MD. We use modified CD8 T cells to battle cancer, with 2 innovations that will 1) be less burden to the patient, and 2) propel T cell therapy to success against solid tumors. Our company was founded in 2016 when our founder, orthopedic surgeon Yong H. Park, MD, began to explore opportunities for medical impact on a greater scale. While living in the DC area, he began work on NIH-patented T cell technologies. In 2018, he partnered with immunologist Rho H. Seong, PhD from Seoul National University, for validation studies. The two formed an immediate connection that ultimately led to a company partnership.